New synthetic cannabinoids and the potential for cardiac arrhythmia risk
Jules C Hancox, Caroline S Copeland, Stephen C Harmer, Graeme Henderson · 2023
Read New synthetic cannabinoids and the potential for cardiac arrhythmia risk by Jules C Hancox, Caroline S Copeland, Stephen C Harmer, Graeme Henderson (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10739592.txt.
Description
Jules Hancox and three co-authors assess new synthetic cannabis-like drugs in a 2023 paper. These drugs have been linked to a longer heart signal interval, which can raise the risk of dangerous rhythms. Hard data are scarce because new versions appear fast and research access is limited.
The team used two learning-based tools to test how seven new compounds might act on a key heart channel. Five were flagged by both tools as likely blockers of that channel, and one looked especially strong. Two others gave mixed readings. The authors say the results point to a real rhythm risk and call for detailed safety checks.
Catalog record
| CREATOR | Jules C Hancox, Caroline S Copeland, Stephen C Harmer, Graeme Henderson |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 16 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |